Toxicity of arsenic (III) on isolated liver mitochondria: A new mechanistic approach

Iranian Journal of Pharmaceutical Research

Volumn 12, Issue SUPPL., 2013, Pages 119-136

  Hosseini, Mir Jamal ^a,b,c   Shaki, Fatemeh ^a,d   Ghazi Khansari, Mahmoud ^e   Pourahmad, Jalal ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Arsenic (III); Complex I; Complex II; Liver toxicity; Mitochondria; Mitochondrial permeability transition (MPT); Reactive Oxygen Species (ROS)

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ARSENIC; CYTOCHROME C OXIDASE; GLUTATHIONE; HYDROGEN PEROXIDE; LUCIFERASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUCCINATE DEHYDROGENASE; UBIQUINOL CYTOCHROME C REDUCTASE;

ARTICLE; FLOW CYTOMETRY; LIPID PEROXIDATION; LIVER MITOCHONDRION; LIVER TOXICITY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION SWELLING; NONHUMAN; OXIDATIVE PHOSPHORYLATION; RAT;

EID: 84875161129     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Jarup L. Hazards of heavy metal contamination. Br. Med. Bull. (2003) 68: 167-82.
2. Zhang TD, Chen GQ, Wang ZG, Zhen YW, Chen SJ, Chen Z. Arsenic trioxide, a therapeutic agent for APL. Oncogene (2001) 20: 7146-53.
3. Yen CC, Ho TJ, Wu CC, Chang CF, Su CC, Chen YW, Jinn TR, Lu TH, Cheng PW, Su YC, Liu SH, Huang CF. Inorganic arsenic causes cell apoptosis in mouse cerebrum through an oxidative stress-regulated signaling pathway. Arch. Toxicol (2011) 85: 565-75.
4. Kitchin KT. Recent advances in carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. (2001) 172: 249-61.
5. Liu J, Waalkes MP. Liver is a target of arsenic carcinogenesis. Toxicol. Sci. (2008) 105: 24-32.
6. Pourahmad J, Rabiei M, Jokar F, Obrien PJ. A comparison of hepatocyte cytotoxic mechanisms for chromate and arsenite. Toxicology (2005) 206: 449-60.
7. Han YH, Kim SZ, Kim SH, Park WH Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH. Cancer Lett. (2008) 270:40-55.
8. Yen Y-P, Tsai K-S, Chen Y-W, Huang C-F, Yang R-S, Liu S-H. Arsenic induces apoptosis in myoblasts through a reactive oxygen species-induced endoplasmic reticulum stress and mitochondrial dysfunction pathway. Arch. Toxicol. (2012) 86: 923-33.
9. Bustamante J, Nutt L, Orrenius S, Gogvadze V. Arsenic stimulates release of cytochrome c from isolated mitochondria via induction of mitochondrial permeability transition. Toxicol. Appl. Pharmacol. (2005) 207: 110-6.
10. Beyersmann D, Hartwig A. Carcinogenic metal compounds: recent insight in to molecular and cellular mechanisms. Arch. Toxicol. (2008) 82: 493-512.
11. Shi H, Shi X, Liu KJ. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol. Cell. Biochem (2004) 255: 67-78.
12. Libby P. Inflammation in atherosclerosis. Nature. (2002) 420: 868-74.
13. Tahara, EB, Navarete FD, Kowaltowski AJ. Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation. Free Radic. Biol. Med. (2009). 46: 1283-97.
14. Pourahmad J, Hosseini M-J. Application of isolated mitochondria in toxicological and clinical studies. Iranian J. Pharm. Res. (2012) 11:703-704.
15. Pereira CV, Moreira AC, Pereira SP, Machado NG, Carvalho FS, Sardão VA, Oliveira PJ. Investigating Drug-induced Mitochondrial Toxicity: A Biosensor to Increase Drug Safety? Curr. Drug Safe. (2009) 4: 34-54.
16. Hosseini M-J, Shaki F, Ghazi-Khansari M and Pourahmad J. Toxicity of vanadium on isolated rat liver mitochondria: a new mechanistic approach. Metallomics. (2013) 5: 152-166.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem (1976)72: 248-54.
18. Gao X, Zheng CY, Yang L, Tang XC, Zhang HY. Huperzine A protects isolated rat brain mitochondria against β-amyloid peptide. Free Radic. Biol. Med. (2009) 46: 1454-62.
19. Barja G. The Quantitative Measurement of H2O2 Generation in Isolated Mitochondria. J. Bioenerg Biomembr (2002) 34: 227-33.
20. Zhao Y, Ye L, Liu H, Xia Q, Zhang Y, Yang X, Wang K. Vanadium compounds induced mitochondria permeability transition pore (MPT) opening related to oxidative stress. J. Inorg. Biochem (2010) 104: 371-78.
21. Zhang F, Xu Z, Gao J, Xu B, Deng Y. In vitro effect of manganese chloride exposure on energy metabolism and oxidative damage of mitochondria isolated from rat brain. Environ Toxicol. Pharmacol.(2008) 26: 232-6.
22. Sadegh C, Schreck RP. The spectroscopic determination of aqueous sulfite using Ellman's reagent. MIT Undergrad Res. J. (2003) 8: 39-43.
23. Baracca A, Sgarbi G, Solaini G, Lenaz G. Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F(0) during ATP synthesis. Biochim Biophys. Acta. (2003) 1606:137-46.
24. Tafreshi NKh, Hosseinkhani S, Sadeghizadeh M, Sadeghi M, Ranjbar B, Naderi-Manesh H. The influence of insertion of a critical residue (Arg356) in structure and bioluminescence spectra of firefly luciferase. J. Biol. Chem. (2007) 282: 8641-7.
25. Armstrong JS. Mitochondrial Medicine: Pharmacological targeting of mitochondria in disease. Br. J. Pharmacol (2007) 151: 1154-65.
26. Bolt HM, Stewart JD. Antioxidant activity of food constituents: relevance for the risk of chronic human diseases. Arch. Toxicol. (2012) 86: 343-4.
27. Vergun O, Votyakova TV, Reynolds IJ Spontaneous Changes in Mitochondrial Membrane Potential in Single Isolated Brain Mitochondria. Biophysical. J. (2003) 85: 3358-66.
28. Shaki F, Pourahmad J. Mitochondrial Toxicity of Depleted Uranium: Protection by Beta-Glucan. Iranian J. Pharm. Res. (2013) 12: 131-140.
29. Larochette N, Decaudin D, Jacotot E, Brenner C, Marzo I, Susin SA, Zamzami N, Xie Z, Reed J, Kroemer G. Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Exp. Cell. Res. (1999) 249: 413-21.
30. Soucy NV, Ihnat MA, Kamat CD, Hess L, Post MJ, Klei LR, Clark C, Barchowsky A. Arsenic stimulates angiogenesis and tumorigenesis in-vivo. Toxicol. Sci. (2003) 76: 271-9.
31. Kao YH, Yu CL, Chang LW, Yu HS. Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro. Chem Res Toxicol (2003) 16: 460-8.
32. Miller Jr, Schipper WH, Lee HM, Singer JS, Waxman S. Mechanisms of action of arsenic trioxide. Cancer Res. (2002) 62: 3893-903.
33. Jimi S, Uchiyama M, Takaki A, Suzumiya J, Hara S. Mechanisms of cell death induced by cadmium and arsenic. Ann. NY Acad. Sci. (2004) 1011: 325-31.
34. Jomova K, Jenisova Z, Feszterova M, Baros S, Liska J, Hudecova D, Rhodes CJ, Valko M. Arsenic: toxicity, oxidative stress and human disease. J. Appl. Toxicol. (2011) 31: 95-107.
35. Raha S, Robinson BH. Mitochondria, oxygen free radicals, disease and aging. Trends. Biochem. Sci. (2000) 25: 502-7.
36. Pourahmad J, OBrien PJ, Jokar F, Daraei B. Carcinogenic metal induced sites of reactive oxygen species formation in hepatocytes. Toxicol in-vitro (2003) 17: 803-10.
37. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, MarcacciomM, Pinton P, Rizzutom R, Bernardi P, Paolucci F. Pelicci, PG. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell (2005) 122: 221-33.
38. Shaki F, Hosseini M-J, Ghazi-Khansari M and Pourahmad J. Toxicity of depleted uranium on isolated rat kidney mitichondria. Biochem. Biophys. Acta. (2012) 1820: 1940-1950.
39. Lash LH. Mitochondrial glutathione transport: Physiological, pathological and toxicological implications. Chem. Biol. Interact. (2006) 163: 54-67.
40. Sims, NR, Nilsson M, Muyderman H. Mitochondrial glutathione: a modulator of brain cell death. J. Bioenerg Biomembr (2004) 36: 329-33.
41. Keil U, Scherping I, Hauptmann S, Schuessel K, Eckert A, Muller WE. Piracetam improves mitochondrial dysfunction following oxidative stress. Br. J. Pharmacol. (2006) 147: 199-208.
42. Pourahmad J, Hosseini M-J, Eskandari MR, Shekarabi MR and Daraie B. Mitichondrial?lysosomal toxic cross-talk play a key rol in cisplatin nephrotoxicity. Xenobiotica. (2010) 40: 763-771.
43. Hayakawa T, Kobayashi Y, Cui X, Hirano S. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch. Toxicol. (2005) 79: 183-91.
44. Nutt LK, Gogvadze V, Uthaisang W, Mirnikjoo B, McConkey DJ, Orrenius S. Indirect effects of Bax and Bak initiate the mitochondrial alterations that lead to cytochrome c release during arsenic trioxide-induced apoptosis. Cancer Biol. Ther. (2005) 4: 459-67.
45. Sternsdorf T, Puccetti E, Jensen K, Hoelzer D, Will H, Ottmann OG, Ruthardt M. PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Mol. Cell Biol. (1999) 19: 5170-8.
46. Drew B, Leeuwenburg C. Method for measuring ATP production in isolated mitochondria:ATP production in brain and liver mitochondria of Fischer-344 rats with age and caloric restriction. Am. J. Physiol. Integr. Comp. Physiol. (2003) 285: 1259-68.